Randomized Phase I/II Trial of LB-100 Plus Doxorubicin vs Doxorubicin Alone of Advanced Soft Tissue Sarcomas

Condition:   Advanced Soft-tissue Sarcoma Interventions:   Drug: LB-100 plus Doxorrubicin;   Drug: Doxorubicin Sponsor:   Grupo Espanol de Investigacion en Sarcomas Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials